Hi-Clearance Inc. (TPEX:1788)

Market Cap	6.43B
Revenue (ttm)	4.07B
Net Income (ttm)	359.69M
Shares Out	44.52M
EPS (ttm)	8.07
PE Ratio	17.91
Forward PE	n/a
Dividend	7.00 (4.84%)
Ex-Dividend Date	Jun 14, 2024

Volume	246
Average Volume	38,466
Open	141.50
Previous Close	144.50
Day's Range	141.50 - 144.50
52-Week Range	130.00 - 147.00
Beta	0.18
RSI	59.87
Earnings Date	Apr 1, 2025

About Hi-Clearance

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysis centers; and sale and servi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1788

Financial Performance

In 2023, Hi-Clearance's revenue was 3.90 billion, a decrease of -16.93% compared to the previous year's 4.69 billion. Earnings were 347.98 million, a decrease of -5.03%.